Small Cap Feast

Small Cap Feast – 04 September 2019

Set Menu AIM:

Total number of AIM Companies (Incl Susp): 878

Total number of AIM Companies trading: 797*
* As at 02 September 2019

Set Menu NEX Growth:

Total number of NEX Growth Market Companies (Incl Susp): 87*

Total number of NEX Growth Market Companies trading: 85*
* As at 02 September 2019

Set Menu Standard List:

Total number of Standard List Companies (Incl Susp): 166*

Total number of Standard List Companies trading: 144*
* As at 02 September 2019

Dish of the Day:

SEC S.p.A. Re-introduction  to AIM  following a reverse takeover under Rule 14 by SEC S.p.A of Porta Communications plc, another AIM quoted company. No funds being raised. Due 4 September. Mkt cap c £9.9m. The merger will create a business with global fee income of around €80m and a host of PR agencies, including Newgate, Publicasity and Newington.

Off the Menu:

Porta Communications (PTCM) –  has been delisted following its merger with SEC. The Merger constituted a reverse takeover under the AIM Rules for Companies with 1 New SEC Share for every 88.4955752 Scheme Shares .

Dish of the Day:

No Joiners Today

Off the Menu:

No Leavers Today

What’s Cooking in the IPO Kitchen?

NEX

Bracken Trading — The Group undertakes its main trade of lending as well as electricity generation through the operation of two solar farms. Admission on the 09/09/2019

Breakfast Buffet

Crossword Cybersecurity* (CCS) 510p £23.87m

Announced the launch of Rizikon Assurance 2.0, an online solution to the problem of third-party risk.  The new version allows organisations to visualise all risks for each third-party through fully customisable 360-degree supplier scorecards.  The new Third-party Assurance Framework Dashboard – an industry first – gives Supplier Management teams, Chief Risk Officers and senior executives a complete understanding of third-party risks across their supply chain, helping identify problem areas and prioritise remedial action.

Rizikon Assurance helps companies address the pressure from Regulators, Auditors, Compliance professionals and customers to improve third-party assurance & risk management.  It supports the Rizikon Supplier Assurance Framework,  an optional, technology independent, methodology for organising, managing and measuring third-party risks.

Petards Group* (PEG) 20.50p £11.32m

Petards, the AIM quoted developer of advanced security and surveillance systems, announced that it had been awarded a £1.1 million contract by a major UK defence systems contractor to provide Electronic Countermeasures equipment for use on a UK Ministry of Defence (“MOD”) programme.

 The contract is for the manufacture and supply of equipment that will form part of an integrated Defensive Aids Suite on military aircraft.  Most of the equipment is expected to be delivered in the second half of 2020.

Commenting, Raschid Abdullah, Petards Chairman said: “We are delighted to have been reselected for the next phase of this electronic countermeasures project which will serve to protect aircraft and the lives of the Service Personnel that fly in them. The Company has been supplying and servicing such systems for many years and we believe that this is indicative of the value that our customer places on our expertise in this specialist field”.

Kingswood Holdings (KWG) 8p £17.35m

Kingswood Holdings Limited, the integrated wealth management group, announced the acquisition of the business and assets of WFI Financial, a significant independent regional financial planning business based in Sheffield. The Acquisition marks the continuation of the Group’s expansion of its national wealth management footprint to the Midlands and the North. The Acquisition is expected to be immediately earnings accretive to the Group.

Kingswood has exchanged contracts to acquire the WFI book of business for a maximum cash consideration of £14.0 million which will be payable over a 30-month period; £3.5m will be payable at closing of the Acquisition and the balance on a deferred basis subject to WFI meeting pre-agreed asset migration, recurring revenue and EBITDA hurdles over a 30 month period, with the final deferred payment due in February 2022. In the most recent financial year to 30 June 2019, the WFI business generated EBITDA in the order of £1.8 million.

Quiz (QUIZ) 15.75p £23m

Group revenues during the Period are broadly in line with the same period last year (after adjusting for the unprofitable revenue streams which have been terminated during the year). The challenging trading conditions reported at the time of the Group’s announcement on 11 June 2019 have persisted over the summer months.

Consistent with the widely reported conditions on the UK high street, the business has experienced a reduction in store footfall during the Period compared to the previous year when the Group experienced particularly strong demand. The Group’s performance has continued to benefit from sales growth through QUIZ’s own websites.

Whilst trading conditions are expected to remain difficult, the Board continues to believe that, through the strength of QUIZ’s flexible business model and increasing online focus, the Group can return to sustainable profitable growth in the medium term.

mporium Group (MPM) 1.15p £11.75m

Mporium Group plc, the technology firm delivering event-driven marketing, announced a commercial partnership with Click Labs Group, a performance marketing agency specialising in the design, build and deployment of multi-channel lead generation campaigns.

The collaboration will see Mporium deploying its IMPACT technology across Click Labs’ core clients to enhance the performance of established and new customer acquisition programmes. In addition, Click Labs will work closely with the existing Mporium Lead Generation division to accelerate revenue growth, focused initially on financial services and claims management clients, prior to further roll out across their portfolio of sports, health, homeware and utilities clients. The Company will receive a share of revenue pursuant to the collaboration.

Stirling Industries (STRL) 42.50p £3.8m

Stirling notes that, since the announcement of its results for the period ending 31 March 2019 and the update provided with respect to the potential acquisition of its first operating asset, there has been rumour and speculation regarding the identity of the Company’s first potential acquisition.

Stirling confirms that the target in question is Ipsen International GmbH.

Ipsen is the market-leading global provider of heat treatment equipment and associated aftermarket services, selling into a range of sectors with attractive market fundamentals. Ipsen supplies a wide range of ‘blue chip’ global OEMs across the aerospace, manufacturing, automotive, and broader industrial sectors, and has a diversified geographic footprint and revenue base.

Gaming Realms (GMR) 6.05p £17.63m

Gaming Realms plc, the developer and licensor of mobile focused, real money games, announced that it has launched Slingo Originals content with leading Stockholm-listed online gaming operator Betsson Group, which holds gaming licences in twelve countries across Europe.

Under the terms of the agreement, Slingo games, including the popular Slingo Rainbow Riches, Slingo Extreme and Slingo XXXtreme, will launch across Betsson Group’s global network of brands, including Betsson, Betsafe, NordicBet, CasinoEuro and Europebet. The agreement will expand Gaming Realms’ international reach and further consolidate its presence in the UK and Scandinavian markets.

Audioboom Group (BOOM) 210p £29.41m

Audioboom, the leading global podcast company, announces an advertising technology partnership with Voxnest, Inc, a leading b2b technology provider. Audioboom and Voxnest have worked together over several months to develop a scalable podcast advertising system that can quickly deliver ads to Audioboom’s inventory of podcasts.

In 2018, Audioboom began the search for a tool that could move its advertising technologies forward and has now selected Voxnest as its exclusive partner to enhance Audioboom’s existing technology. The new advertising system was built and tested by both companies, resulting in technical advances ranging from core code through to final delivery platforms.

Scancell Hlds (SCLP) 7.25p £27.34m

Scancell, the developer of novel immunotherapies for the treatment of cancer, announced that it has signed its first collaboration and non-exclusive research agreement with a leading antibody technology company to assess its pipeline of monoclonal antibodies  targeting tumour-associated glycans that have been enhanced with its new proprietary AvidiMab™ technology.

Mobile Streams (MOS) 0.1p £0.26m

Mobile Streams plc, announces its intention to seek Shareholder approval for the cancellation of admission of its ordinary shares to trading on AIM, re-registration as a private limited company and adoption of new articles of association.

Head Chef:

Derren Nathan
0203 764 2344
derren.nathan@hybridan.com

*A corporate client of Hybridan LLP

Disclaimer

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.